Ontology highlight
ABSTRACT: Background
Congenital fibrinogen deficiency (CFD) is a rare bleeding disorder characterized by reduced levels (afibrinogenemia, hypofibrinogenemia) or dysfunctional fibrinogen (dysfibrinogenemia), for which fibrinogen supplementation is the mainstay treatment.Objectives
To assess the efficacy and safety of human fibrinogen concentrate (FCH) in patients with CFD.Methods
This was a multicenter, noninterventional, retrospective cohort study with a 12-month prospective follow-up period in the United States and Canada. Individuals with CFD who received FCH for the treatment of bleeding, perioperative hemostasis, or prophylaxis were included. Data were collected retrospectively from medical records and every 3 months during the prospective period. Hemostatic efficacy was
SUBMITTER: Lasky J
PROVIDER: S-EPMC7695557 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature